diflucan 100 mg trde kapsule
pfizer luxembourg sarl - flukonazol - kapsula, trda - flukonazol 100 mg / 1 kapsula - flukonazol
diflucan 150 mg trde kapsule
pfizer luxembourg sarl - flukonazol - kapsula, trda - flukonazol 150 mg / 1 kapsula - flukonazol
diflucan 100 mg trde kapsule
pfizer luxembourg sarl - flukonazol - kapsula, trda - flukonazol 100 mg / 1 kapsula - flukonazol
diflucan 50 mg trde kapsule
pfizer luxembourg sarl - flukonazol - kapsula, trda - flukonazol 50 mg / 1 kapsula - flukonazol
caduet 5 mg/10 mg filmsko obložene tablete
pfizer luxembourg sarl - amlodipin; atorvastatin - filmsko obložena tableta - amlodipin 5 mg / 1 tableta atorvastatin10 mg / 1 tableta; atorvastatin 10 mg / 1 tableta - atorvastatin in amlodipin
caduet 10 mg/10 mg filmsko obložene tablete
pfizer luxembourg sarl - amlodipin, atorvastatin - filmsko obložena tableta - amlodipin 10 mg / 1 tableta; atorvastatin 10 mg / 1 tableta - atorvastatin in amlodipin
champix
pfizer europe ma eeig - vareniklin - uporaba tobaka v prenehanju - druga zdravila na živčnem sistemu - champix je indiciran za prenehanje kajenja pri odraslih.
xalkori
pfizer europe ma eeig - krizotinib - karcinom, pljučni pljuč - antineoplastična sredstva - xalkori as monotherapy is indicated for:the first‑line treatment of adults with anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc)the treatment of adults with previously treated anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc)the treatment of adults with ros1‑positive advanced non‑small cell lung cancer (nsclc)the treatment of paediatric patients (age ≥6 to.
sutent
pfizer limited - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastična sredstva - gastrointestinal stromal tumour (gist)sutent is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib mesilate treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sutent is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sutent is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours with disease progression in adults. experience with sutent as first-line treatment is limited (see section 5.
daurismo
pfizer europe ma eeig - glasdegib maleate - leukemija, myeloid, akutna - antineoplastična sredstva - daurismo is indicated, in combination with low-dose cytarabine, for the treatment of newly diagnosed de novo or secondary acute myeloid leukaemia (aml) in adult patients who are not candidates for standard induction chemotherapy.